IRIS
DE VITO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.769
AS - Asia 2.547
SA - Sud America 1.805
EU - Europa 1.149
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AN - Antartide 1
Totale 15.395
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.611
BR - Brasile 1.628
SG - Singapore 1.265
CN - Cina 383
HK - Hong Kong 373
IT - Italia 323
DE - Germania 262
FI - Finlandia 138
VN - Vietnam 137
GB - Regno Unito 81
AR - Argentina 72
CA - Canada 71
MX - Messico 53
TR - Turchia 50
BD - Bangladesh 46
UA - Ucraina 45
IN - India 42
RU - Federazione Russa 41
FR - Francia 38
ZA - Sudafrica 32
EC - Ecuador 31
IQ - Iraq 26
JP - Giappone 25
NL - Olanda 25
PK - Pakistan 25
VE - Venezuela 25
CZ - Repubblica Ceca 24
ES - Italia 24
ID - Indonesia 23
CO - Colombia 21
MA - Marocco 20
PL - Polonia 20
SE - Svezia 20
KR - Corea 19
AT - Austria 18
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 15
LT - Lituania 14
IL - Israele 13
BE - Belgio 11
JM - Giamaica 10
NP - Nepal 10
TN - Tunisia 10
UY - Uruguay 10
AZ - Azerbaigian 9
KG - Kirghizistan 9
RO - Romania 9
RS - Serbia 9
UG - Uganda 9
DO - Repubblica Dominicana 8
KE - Kenya 8
IE - Irlanda 7
JO - Giordania 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
EG - Egitto 6
PE - Perù 6
AU - Australia 5
BG - Bulgaria 5
HU - Ungheria 5
LB - Libano 5
PY - Paraguay 5
AL - Albania 4
DZ - Algeria 4
GE - Georgia 4
HN - Honduras 4
KZ - Kazakistan 4
MY - Malesia 4
OM - Oman 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CL - Cile 3
GR - Grecia 3
MK - Macedonia 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
MZ - Mozambico 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
Totale 15.371
Salva come PNG Salva come JPEG
Città #
Dallas 7.696
Singapore 701
Hong Kong 370
Chandler 345
New York 222
Ashburn 190
Beijing 175
Munich 165
São Paulo 124
Helsinki 100
Los Angeles 93
Princeton 68
Sassari 62
Rio de Janeiro 60
Shanghai 54
Belo Horizonte 48
Ho Chi Minh City 41
Santa Clara 38
Brasília 37
Columbus 32
Hanoi 32
Boardman 30
Curitiba 30
Montreal 28
Rome 26
Denver 25
Brno 24
Tokyo 24
Frankfurt am Main 22
Campinas 21
Atlanta 20
The Dalles 20
Fortaleza 19
London 19
Warsaw 19
Johannesburg 18
Salvador 18
Brooklyn 17
Chennai 17
Palermo 17
Seoul 17
Turku 17
Amsterdam 16
Chicago 16
Guarulhos 16
Nuremberg 16
Porto Alegre 16
Recife 16
Wilmington 16
Sorocaba 15
Toronto 15
Ankara 14
Falkenstein 14
Guayaquil 14
Lappeenranta 14
Poplar 14
Stockholm 14
Boston 13
Cagliari 13
Goiânia 13
Orem 13
Phoenix 13
Ribeirão Preto 13
San Francisco 13
Tashkent 13
Düsseldorf 12
Houston 12
São José dos Campos 12
Buffalo 11
Contagem 11
Dhaka 11
Florianópolis 11
Santo André 11
Xi'an 11
Alghero 10
Brussels 10
Jacksonville 10
Lahore 10
Mexico City 10
Romola 10
Baghdad 9
Bishkek 9
Istanbul 9
Kampala 9
Mumbai 9
Nova Iguaçu 9
Osasco 9
Ottawa 9
Rio Grande 9
Baku 8
Buenos Aires 8
Duque de Caxias 8
Ipatinga 8
Joinville 8
João Pessoa 8
Mountain View 8
Nairobi 8
Querétaro 8
São Luís 8
Turin 8
Totale 11.762
Salva come PNG Salva come JPEG
Nome #
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 821
Chain of thought reasoning in enhancing infectious disease diagnosis and microbiological analysis 716
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 637
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 625
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 560
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 517
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 514
Diagnostic Performance of ChatGPT-4o in Analyzing Oral Mucosal Lesions: A Comparative Study with Experts 501
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 291
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 269
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 256
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 250
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 247
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 243
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 241
Fluoroquinolones and Biofilm: A Narrative Review 223
A case of vasculitis-like skin eruption associated with COVID-19 182
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 165
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 154
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 153
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 146
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 144
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 142
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 135
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 131
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 131
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 128
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 127
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 127
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 123
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 119
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 118
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 114
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 113
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 113
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 113
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 111
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 111
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 111
Infectious diseases screening approach among refugees: Results from a single-center study 111
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 109
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 109
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 108
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 107
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 107
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 106
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 100
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 100
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 100
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 99
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 98
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 95
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 95
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 93
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 93
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 93
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 90
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 90
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 90
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 89
Exploring the Impact of Cabotegravir-Rilpivirine Long-Acting on Weight Gain, Body Composition, and Quality of Life in Adults Living with HIV 88
HBV in Italian Women’s Jail: An Underestimated Problem? 86
What do We Know about Cryptic Aspergillosis? 85
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 83
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 83
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 82
The current and future off-label uses of dalbavancin: a narrative review 82
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 80
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 80
Living with HIV and Getting Vaccinated: A Narrative Review 79
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 78
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 78
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 77
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 75
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 74
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 73
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 73
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 72
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges 72
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 71
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 70
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 70
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 69
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 69
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 69
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 68
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 67
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 66
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 66
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 66
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 65
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 64
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 62
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 62
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 61
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 61
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 61
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 61
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 60
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 59
Totale 14.871
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.306
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 16 10 23 44 17 0 0
2021/2022177 4 4 5 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20253.718 50 36 183 136 159 151 387 643 1.139 540 185 109
2025/202610.347 322 1.344 6.909 955 757 60 0 0 0 0 0 0
Totale 15.570